Catalysts
TWST Stock Catalysts
Earnings · Growth Drivers · Events · AIQ Catalyst
TWSTTwist Bioscience Corporation
Healthcare / Biotechnology
Low Priority
Above Peers
Latest quote
- Momentum84
- Value58
- Quality59
- Risk resilience32
- Sentiment—
Stock Catalyst Board
Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.
Upcoming reporting date available for this company.
Momentum 84/100 and sentiment — before the next covered event.
Updated Nov 15, 2026 · Sentiment 40.60%
Earnings History And Surprises
See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.
Earnings Expectations And Results
Compare what analysts expected with what the company reported across recent quarters.
| Report date | Fiscal period | EPS estimate | EPS actual | EPS surprise | Revenue estimate | Revenue actual |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | — | -$0.39 | -$0.32 | +17.3% | $123.55M | $126.64M |
| Aug 3, 2026 | — | -$0.51 | -$0.56 | -10.6% | $114.55M | $118.4M |
| May 4, 2026 | — | -$0.49 | -$0.71 | -44.9% | $107.64M | $110.72M |
| Feb 2, 2026 | — | -$0.48 | -$0.50 | -4.2% | $101.88M | $103.7M |
| Nov 14, 2025 | — | -$0.50 | -$0.45 | +10.0% | $97.4M | $99.01M |
| Aug 4, 2025 | — | -$0.54 | -$0.47 | +13.0% | $97.38M | $96.06M |
| May 5, 2025 | — | -$0.56 | -$0.66 | -17.9% | $95.39M | $92.79M |
| Feb 3, 2025 | — | -$0.62 | -$0.53 | +14.5% | $86.95M | $88.71M |
Analyst Forecast And Price Targets
Wall Street consensus, rating distribution, and the current 12-month target range.
Event Read
Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.
Current event setup
Next known earnings or reporting date.
Current analyst expectation for the upcoming report.
Current analyst expectation for the upcoming report.
News pressure around the setup.
Where event reaction would show up first.
Composite decision read before event confirmation.
Analyst context
News And Sentiment
Recent company coverage, scored where source sentiment is available.
Full-Year Revenue Guidance and Strong Quarter Drove Twist Bioscience Corporation (TWST) Higher in Q3
Artisan Partners, an investment management company, released its third-quarter 2026 investor letter for the “Artisan U.S. Small-Cap Growth Strategy”. The letter can be downloaded here.
Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership
Twist Bioscience Corporation (NASDAQ:TWST) is on the cusp of gaining significant exposure to the rapidly evolving artificial intelligence (AI)-driven drug discovery ecosystem. On September 16, the company confirmed a strategic partnership with Lilly TuneLab, a platform created by Eli Lilly and Company (NYSE:LLY). As part of the strategic partnership, Twist will provide antibody characterization data […]
Related Links
TWST Catalysts FAQ
What are the next catalysts for TWST stock?
TWST's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.
What upcoming events could move TWST stock?
Upcoming events that could move TWST include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.
How could TWST's next earnings report affect the stock?
TWST's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.
What could drive TWST stock higher?
TWST could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.
What events could hurt TWST stock?
TWST could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.